DOCSLIB.ORG

Extended Polyglutamine Selectively Interacts with Caspase-8 and -10 in Nuclear Aggregates

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Extended Polyglutamine Selectively Interacts with Caspase-8 and -10 in Nuclear Aggregates Cell Death and Differentiation (2001) 8, 377 ± 386 ã 2001 Nature Publishing Group All rights reserved 1350-9047/01 $15.00 www.nature.com/cdd Extended polyglutamine selectively interacts with caspase-8 and -10 in nuclear aggregates 1 ,1 1 1 MU, T Miyashita* , Y Ohtsuka , Y Okamura-Oho , Introduction Y Shikama1 and M Yamada1 To date, eight neurodegenerative disorders including 1 Department of Genetics, National Children's Medical Research Center, Huntington's disease (HD) and dentatorubral pallidoluysian 3-35-31, Taishido, Setagaya, Tokyo 154-8509, Japan atrophy (DRPLA), have been shown to be caused by the * Corresponding author: T Miyashita, Department of Genetics, National expansion of CAG repeats.1,2 The CAG repeats are located in Children's Medical Research Center, 3-35-31, Taishido, Setagaya, Tokyo the coding regions of the respective responsible genes and 154-8509, Japan. Tel: +81-3-3414-8121; Fax: +81-3-3414-3208; are translated into polyglutamine. These disorders, collec- E-mail: [email protected] tively called CAG-repeat disorders or polyglutamine diseases, Received 30.5.00; revised 18.10.00; accepted 21.11.00 are characterized by neuron death in the region specific to 3 Edited by DR Green each disease. The molecular mechanism underlying these disorders has yet to be clarified. However, accumulating evidence suggests that caspases, at least in part, are involved Abstract in the neurodegeneration. Caspases constitute a family of cysteine proteases that A growing number of inherited neurodegenerative disorders, play important roles in the execution of apoptosis. Each of including Huntington's disease, have been shown to be these enzymes is synthesized as a zymogen and caused by the expansion of CAG/polyglutamine repeats. The proteolytically activated by its own active form or other molecular mechanism underlying these disorders, however, members of caspases.4 Involvement of caspases in CAG- has yet to be clarified. We and others previously demonstrated repeat disorders are supported by three groups of that caspase-8 was activated by proteolysis in association observations: (i) Some of the products of the genes with the expression of extended polyglutamine. Here, we responsible for CAG-repeat disorders are substrates for further analyzed the selectivity of caspases in the process caspases, and their cleaved fragments carrying extended 5±8 mediated by extended polyglutamine. Among upstream polyglutamine tend to easily form aggregates; (ii) an caspases, caspase-10, a close homolog of caspase-8, was activated form of caspases has been detected in the also proteolytically activated, but caspase-9 was not. affected regions of the brains of patients and of model animals as well as in cultured cells of experimental Caspase-8 and -10 were recruited into nuclear aggregates of systems;9±11 and (iii) inhibition of caspases slows cell extended polyglutamine, where at least a fraction of these death or suppresses the apoptotic nuclear phenotype in caspases was converted to the activated forms. Caspase-8 model animals as well as in in vitro experimental and -10 were co-immunoprecipitated with polyglutamine only systems.10,12 when the polyglutamine was pathologically extended, We previously demonstrated that expression of extended whereas caspase-2, -3, -6, -7 and -9 were not co-immunopre- polyglutamine sequentially activated caspase-8 and then cipitated with polyglutamine regardless of its size. A caspase-3.9 SaÂnchez et al.10 also reported detection of the dominant-negative form of caspase-8 with a mutation at the proteolytically activated form of caspase-8 in the affected catalytic cysteine residue inhibited polyglutamine-mediated brain region of HD patients. Caspase-8 (MACH/FLICE/ nuclear apoptotic phenotype. These results suggest that Mch5) was originally cloned as a protein that interacts with caspase-8 and -10 are autoactivated as a result of close FADD (MORT1), a mediator of Fas (CD95/APO-1)-induced apoptosis, or as a component of death-inducing signaling proximity of the proforms of these molecules that occurs due complex (DISC).13,14 The targeted disruption of the to aggregate formation, which reveals a novel toxic gain-of- caspase-8 gene is lethal in utero and the TNF receptors, function mechanism for the pathogenesis of CAG-repeat Fas, and DR3 failed to induce cell death in embryo disorders. Cell Death and Differentiation (2001) 8, 377 ± 386. fibroblasts containing a disrupted caspase-8 gene.15 To analyze the selectivity of caspases during the process of cell death mediated by extended polyglutamine Keywords: polyglutamine; caspase; CAG repeats; Huntington's and to further investigate the mechanism of caspase disease activation, we have analyzed the interaction of polygluta- mine and various caspases. We show here that poly- Abbreviations: DISC, death-inducing signaling complex; DRPLA, glutamine preferentially interacts with and activates dentatorubral pallidoluysian atrophy; GFP, green ¯uorescent caspase-8 and its close homolog, caspase-10 (Mch4/ protein; HD, Huntington's disease; PML, promyelocytic leukemia FLICE2),16,17 and suggest a novel caspase-8- or -10- protein; TC, tetracycline; TRITC, tetramethylrhodamine isothiocya- mediated cell death pathway alternative to Fas-mediated nate; z-VAD-fmk, carbobenzoxy-Val-Ala-Asp-¯uoromethyl ketone apoptosis. Expanded polyglutamine interacts with caspase-8 and -10 MUet al 378 Results the intact form (Figure 1B). The antibody had no cross reactivity with the intact or processed forms of caspase-3, -8, Among initiator caspases, caspase-8 and -10 are -6, or -7 (Figure 1B, and data not shown). These results proteolytically activated by polyglutamine, but indicate that the caspase-9-mediated apoptotic pathway is not caspase-9 is not involved in polyglutamine-induced cell death. We and others previously demonstrated that caspase-8 was cleaved and activated in association with the expression of extended polyglutamine.9,10 In the present study, we first Caspase-8 and -10 colocalize with nuclear examined whether caspase-10, a close homolog of caspase- aggregates of extended polyglutamine 8, was also proteolytically activated during this process. To Initiator caspases such as caspase-8 and -9 were reported to address this question, we utilized the TC-controlled poly- be autoactivated by oligomerization of the molecules21,22 If glutamine expression system in IGROV cells as described procaspase-8 coaggregates with polyglutamine, caspase-8 previously.9 IGROV-EQ19 and IGROV-EQ56 cells express molecules are brought into close proximity and may cleave 19- and 56-stretches of polyglutamine fused with the one another. To test this hypothesis, we first analyzed the enhanced green fluorescent protein (EGFP) (EGFP-polyQ19 subcellular localization of caspases-8 and -10 in the presence and EGFP-polyQ56), respectively, when TC is removed from or absence of nuclear aggregates of extended polyglutamine. the culture medium. The cleaved products of caspase-8 and By immunostaining, caspase-8 and -10 were detected -10 were detected at 72 h after withdrawal of TC only in cells primarily in the cytoplasm (Figure 2B,E, thin arrows). expressing extended polyglutamine (Figure 1A, top and However, in cells with nuclear aggregates of extended middle panels). Another apical caspase that plays an polyglutamine, these caspases were primarily detected in important role in apoptosis is caspase-9 (MCH6), which is the nucleus, and co-localized with the aggregates (Figure 2B, activated by Apaf1 and cytochrome c released from E, thick arrows, and Figure 2C, F). The specificity of the mitochondria.19 In contrast to caspase-8 and -10, the amount results was demonstrated by the absence of co-localization of of the proform of caspase-9 remained constant and the caspase-3 and Bcl-2 with the aggregates (Figure 2G ± L). This cleaved form was not detected by 72 h after the TC also indicates that the nuclear signals in Figure 2B, E are not withdrawal (Figure 1A, bottom panel). The caspase-9 anti- due to the leakage of green fluorescence of GFP- body used in this experiment was confirmed to react with the polyglutamine. processed form of caspase-920 by the use of an engineered construct, caspase-9DC (amino acids 1 ± 315), in addition to Figure 1 Extended polyglutamine activated caspase-8 and -10, but not caspase-9. (A) IGROV-EQ19 and IGROV-EQ56 cells were incubated in the presence or absence of TC. Cell lysates were prepared at 72 h and Western blot analyses were performed using an anti-caspase-8 (upper panel), anti- Figure 2 Co-localization of caspase-8 and -10 with nuclear aggregates of caspase-10 (middle panel), or anti-caspase-9 antibody (lower panel). (B) extended polyglutamine. IGROV-EQ56 cells were incubated in the absence of Proforms and processed forms of caspases were translated in vitro in the TC for 3 days to induce EGFP-polyQ56 expression, and subjected to presence (upper panel) or absence (lower panel) of L-[35S]-methionine. immunostaining followed by confocal microscopy. (A,D,G,J) Green fluores- Translated products were subjected to SDS ± PAGE followed by autoradio- cence shows the presence of EGFP-polyQ56.(B,E,H,K) Red fluorescence graphy (upper panel), or Western blotting using the anti-caspase-9 antibody indicates the localization of endogenous caspase-8, caspase-10, caspase-3, (lower panel). Closed and open arrowheads indicate procaspase-9 and and Bcl-2, respectively, by immunostaining with the respective antibodies. processed caspase-9, respectively (C,F,I,L) Merged images of the left two panels. Bar: 10 mm Cell Death and Differentiation Expanded polyglutamine interacts with caspase-8 and -10 MUet al 379 We then applied the two antisera to the cells expressing Caspase-8 is activated in nuclear aggregates extended polyglutamine and forming nuclear aggregates To test whether caspases were activated in the nuclear as in the experiments shown in Figure 2. Activated aggregates, we raised antibodies that specifically react with a caspase-8 was detected in nuclear aggregates containing processed form of caspase-8 or -9. It has been demonstrated extended polyglutamine (Figure 4A ± C).
Load more

Recommended publications
  • Biochemical Society Focused Meetings Proteases A
    ORE Open Research Exeter TITLE Proteases and caspase-like activity in the yeast Saccharomyces cerevisiae. AUTHORS Wilkinson, D; Ramsdale, M JOURNAL Biochemical Society Transactions DEPOSITED IN ORE 18 November 2013 This version available at http://hdl.handle.net/10871/13957 COPYRIGHT AND REUSE Open Research Exeter makes this work available in accordance with publisher policies. A NOTE ON VERSIONS The version presented here may differ from the published version. If citing, you are advised to consult the published version for pagination, volume/issue and date of publication Biochemical Society Transactions (2011) XX, (XX-XX) (Printed in Great Britain) Biochemical Society Focused Meetings Proteases and caspase-like activity in the yeast Saccharomyces cerevisiae Derek Wilkinson and Mark Ramsdale1 Biosciences, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter, EX4 4QD Key words: Programmed cell death, apoptosis, necrosis, proteases, caspases, Saccharomyces cerevisiae. Abbreviations used: PCD, programmed cell death; ROS, reactive oxygen species; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ER, endoplasmic reticulum; MS, mass spectrometry. 1email [email protected] Abstract A variety of proteases have been implicated in yeast PCD including the metacaspase, Mca1 and the separase Esp1, the HtrA-like serine protease Nma111, the cathepsin-like serine carboxypeptideases and a range of vacuolar proteases. Proteasomal activity is also shown to have an important role in determining cell fate, with both pro- and anti-apoptotic roles. Caspase-3, -6- and -8 like activities are detected upon stimulation of yeast PCD, but not all of this activity is associated with Mca1, implicating other proteases with caspase-like activity in the yeast cell death response.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • The Role of Caspase-2 in Regulating Cell Fate
    cells Review The Role of Caspase-2 in Regulating Cell Fate Vasanthy Vigneswara and Zubair Ahmed * Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham B15 2TT, UK; [email protected] * Correspondence: [email protected] Received: 15 April 2020; Accepted: 12 May 2020; Published: 19 May 2020 Abstract: Caspase-2 is the most evolutionarily conserved member of the mammalian caspase family and has been implicated in both apoptotic and non-apoptotic signaling pathways, including tumor suppression, cell cycle regulation, and DNA repair. A myriad of signaling molecules is associated with the tight regulation of caspase-2 to mediate multiple cellular processes far beyond apoptotic cell death. This review provides a comprehensive overview of the literature pertaining to possible sophisticated molecular mechanisms underlying the multifaceted process of caspase-2 activation and to highlight its interplay between factors that promote or suppress apoptosis in a complicated regulatory network that determines the fate of a cell from its birth and throughout its life. Keywords: caspase-2; procaspase; apoptosis; splice variants; activation; intrinsic; extrinsic; neurons 1. Introduction Apoptosis, or programmed cell death (PCD), plays a pivotal role during embryonic development through to adulthood in multi-cellular organisms to eliminate excessive and potentially compromised cells under physiological conditions to maintain cellular homeostasis [1]. However, dysregulation of the apoptotic signaling pathway is implicated in a variety of pathological conditions. For example, excessive apoptosis can lead to neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, whilst insufficient apoptosis results in cancer and autoimmune disorders [2,3]. Apoptosis is mediated by two well-known classical signaling pathways, namely the extrinsic or death receptor-dependent pathway and the intrinsic or mitochondria-dependent pathway.
    [Show full text]
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]
  • Proteases to Die For
    Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Proteases to die for Vincent Cryns1 and Junying Yuan2,3 1Center for Endocrinology, Metabolism and Molecular Medicine, Northwestern University School of Medicine, Chicago, Illinois 60611 USA; 2Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 USA Apoptosis or programmed cell death (PCD) is a geneti- have identified two genes (ced-3 and ced-4) that are each cally regulated, cellular suicide mechanism that plays a required for the execution of cell death and one (ced-9) crucial role in development and in the defense of homeo- that inhibits cell death (Hengartner et al. 1992; Yuan and stasis. Cells respond to a variety of disparate signals by Horvitz 1992; Yuan et al. 1993). Mutational analyses of committing suicide through a series of dramatic but re- these genes in C. elegans have defined a sequential cell markably uniform events. Morphologically, cells under- death pathway. Inactivating mutations of ced-9 result in going apoptosis demonstrate nuclear/cytoplasmic con- inappropriate cell deaths, but only if both ced-3 and densation and membrane protrusions. These initial ced-4 are functional (Hengartner et al. 1992). Targeted changes are followed by fragmentation of the nuclear overexpression of either ced-4 or ced-3 induces cell contents and subsequent encapsulation of these frag- death, these cell deaths are inhibited by ced-9. In trans- ments into ‘‘apoptotic bodies’’ that are quickly and un- genic worms, maximal cell death induced by ced-4 over- obtrusively consumed by adjacent cells, thereby leaving expression requires ced-3, whereas ced-3-mediated cell little trace of the apoptotic cell’s prior existence (Kerr et death is independent of ced-4.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Anti-Caspase-10 Code No
    M059-3 For Research Use Only. Page 1 of 2 Not for use in diagnostic procedures. MONOCLONAL ANTIBODY Anti-Caspase-10 Code No. Clone Subclass Quantity Concentration M059-3 4C1 Mouse IgG1 100 g 1 mg/mL BACKGROUND: Apoptosis is a major form of cell Detailed procedure is provided in the following death characterized by several morphological features that PROTOCOLS. include chromatin condensation and fragmentation, cell membrane blebbing, and formation of apoptotic bodies. SPECIES CROSS REACTIVITY: These morphological changes occur via signaling pathway that leads to the recruitment and activation of caspases, a Species Human Mouse Rat family of cysteine-containing, aspartate-specific proteases. Jurkat, HeLa, Cells WR19L Not Tested Caspases exist as inactive proenzymes in cells and are U937, HEp-G2 activated through their processing into two subunits in response to apoptotic stimulation. Activated caspases Reactivity on WB + - cleave a variety of important cellular proteins, other caspases, and Bcl-2 family members, leading to a INTENDED USE: commitment to cell death. Caspase-10 (also known as For Research Use Only. Not for use in diagnostic procedures. Mch4, FLICE2 and ICE-LAP4) is a ~58 kDa protein. This caspase acts upstream of the apoptosis induced cascade. Once this caspase is activated by certain apoptotic stimuli, REFERENCES: this protein may be responsible for the activation of the 1) Strauss, G., et al., J. Exp. Med. 206, 1379-1393 (2009) other caspases such as caspase-3, -4, -7, -8, and -9. This 2) Hyer, M. L., et al., Cancer Res. 68, 2927-2933 (2008) antibody was made against human-originated immunogen, 3) Koschny, R., et al., Clin.
    [Show full text]
  • The Pseudo-Caspase FLIP(L) Regulates Cell Fate Following P53 Activation
    The pseudo-caspase FLIP(L) regulates cell fate following p53 activation Andrea Leesa,1, Alexander J. McIntyrea,1, Nyree T. Crawforda, Fiammetta Falconea, Christopher McCanna, Caitriona Holohana, Gerard P. Quinna, Jamie Z. Robertsa, Tamas Sesslera, Peter F. Gallaghera, Gemma M. A. Gregga, Katherine McAllistera, Kirsty M. McLaughlina, Wendy L. Allena, Laurence J. Eganb, Aideen E. Ryanb,c, Melissa J. Labonte-Wilsona, Philip D. Dunnea, Mark Wappetta, Vicky M. Coylea, Patrick G. Johnstona, Emma M. Kerra, Daniel B. Longleya,2,3, and Simon S. McDadea,2,3 aPatrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, Northern Ireland BT9 7BL, United Kingdom; bDiscipline of Pharmacology & Therapeutics, Lambe Institute for Translational Research, School of Medicine, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland; and cRegenerative Medicine Institute, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland Edited by Karen H. Vousden, Francis Crick Institute, London, United Kingdom, and approved June 8, 2020 (received for review February 12, 2020) p53 is the most frequently mutated, well-studied tumor-suppressor switch from cell-cycle arrest to cell death induction remain gene, yet the molecular basis of the switch from p53-induced cell- poorly understood, although p53-mediated transcriptional up- cycle arrest to apoptosis remains poorly understood. Using a combi- regulation of PUMA has been suggested to be crucial in a nation of transcriptomics and functional genomics, we unexpectedly number of studies (10, 11). identified a nodal role for the caspase-8 paralog and only human Despite p53/TP53 being the most frequently mutated gene in pseudo-caspase, FLIP(L), in regulating this switch.
    [Show full text]
  • Caspase Activation & Apoptosis
    RnDSy-lu-2945 Caspase Activation & Apoptosis Extrinsic & Intrinsic Pathways of Caspase Activation CASPASE CLEAVAGE & ACTIVATION Caspases are a family of aspartate-specific, cysteine proteases that serve as the primary mediators of Pro-Domain Large Subunit (p20) Small Subunit (p10) apoptosis. Mammalian caspases can be subdivided into three functional groups, apoptotic initiator TRAIL Pro-Domain α chain β chain caspases (Caspase-2, -8, -9, -10), apoptotic effector caspases (Caspase-3, -6, -7), and caspases involved Asp-x Asp-x Proteolytic cleavage in inflammatory cytokine processing (Caspase-1, -4, -5, 11, and -12L/12S). All caspases are synthesized α chain as inactive zymogens containing a variable length pro-domain, followed by a large (20 kDa) and a small Fas Ligand TRAIL R1 Pro-Domain β chain TRAIL R2 Heterotetramer Formation (10 kDa) subunit. FADD FADD α chain α chain Pro-caspase-8, -10 Active caspase Pro-caspase-8, -10 TWEAK β chain Apoptotic caspases are activated upon the receipt of either an extrinsic or an intrinsic death signal. The Fas/CD95 extrinsic pathway (green arrows) is initiated by ligand binding to cell surface death receptors (TNF RI, Fas/ MAMMALIAN CASPASE DOMAINS & CLEAVAGE SITES FADD FADD TNF-α APOPTOTIC CASPASES CD95, DR3, TRAIL R1/DR4, TRAIL R2/DR5) followed by receptor oligomerization and cleavage of Pro- Extrinsic Pathway DR3 (or another TWEAK R) INITIATOR CASPASES 152 316 331 Pro-caspase-8, -10 Pro-caspase-8, -10 1 435 caspase-8 and -10. Activation of Caspase-8 and Caspase-10 results in the cleavage of BID and Caspase-2 CARD TRADD FLIP TRADD downstream effector caspases.
    [Show full text]
  • Caspases: Pharmacological Manipulation of Cell Death Inna N
    Review series Caspases: pharmacological manipulation of cell death Inna N. Lavrik, Alexander Golks, and Peter H. Krammer Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Heidelberg, Germany. Caspases, a family of cysteine proteases, play a central role in apoptosis. During the last decade, major progress has been made to further understand caspase structure and function, providing a unique basis for drug design. This Review gives an overview of caspases and their classification, structure, and substrate specificity. We also describe the current knowledge of how interference with caspase signaling can be used to pharmacologically manipulate cell death. Introduction involved in the transduction of the apoptotic signal. This superfam- Apoptosis, or programmed cell death, is a common property of all ily consists of the death domain (DD), the death effector domain multicellular organisms (1, 2). It can be triggered by a number of (DED), and the caspase recruitment domain (CARD) (11). Each of factors, including ultraviolet or γ-irradiation, growth factor with- these motifs interacts with other proteins by homotypic interac- drawal, chemotherapeutic drugs, or signaling by death receptors tions. All members of the death domain superfamily are character- (DRs) (3, 4). The central role in the regulation and the execution of ized by similar structures that comprise 6 or 7 antiparallel amphipa- apoptotic cell death belongs to caspases (5–7). Caspases, a family thic α-helices. Structural similarity suggests a common evolutionary of cysteinyl aspartate–specific proteases, are synthesized as zymo- origin for all recruitment domains (12). However, the nature of the gens with a prodomain of variable length followed by a large sub- homotypic interactions differs within the superfamily.
    [Show full text]
  • Serpinb2 Protection of Retinoblastoma Protein from Calpain Enhances Tumor Cell Survival
    Research Article SerpinB2 Protection of Retinoblastoma Protein from Calpain Enhances Tumor Cell Survival Laura Tonnetti,1 Sarah Netzel-Arnett,1 Grant A. Darnell,2 Tamara Hayes,1 Marguerite S. Buzza,1 Ian E. Anglin,1 Andreas Suhrbier,2 and Toni M. Antalis1 1Center for Vascular and Inflammatory Diseases and the Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland and 2Immunovirology Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland, Australia Abstract antiapoptotic activities of Rb include its ability to repress E2F gene transcription (5) and its direct inhibition of proapoptotic The tumor suppressor retinoblastoma protein (Rb) plays a signal transduction (1, 6). Rb ablation leads to up-regulation of pivotal role in the regulation of cell proliferation and E2F, which can sensitize cells to apoptosis (7). Gene expression sensitivity to apoptosis through binding to E2F transcription profiling studies and direct transcription experiments show that factors. Loss of Rb in response to genotoxic stress or up-regulation of E2F1 induces transcription of cell cycle genes, inflammatory cytokines can enhance cell death,in part,by such as the G -S cyclins, and also genes encoding proapoptotic eliminating Rb-mediated repression of proapoptotic gene 1 cell-death machinery, including Apaf-1, p73, procaspase-3, and transcription. Here we show that calpain cleavage of Rb procaspase-7 (8, 9). Because Rb is capable of regulating the facilitates Rb loss by proteasome degradation and that this expression of cell cycle and apoptotic gene targets, additional may occur during tumor necrosis factor A–induced apoptosis. factors in association with Rb likely contribute to ultimate cell fate The cytoprotective,Rb-binding protein SerpinB2 (plasmino- decisions.
    [Show full text]
  • Caspase-10 Is an Initiator Caspase in Death Receptor Signaling
    Caspase-10 is an initiator caspase in death receptor signaling Jin Wang*†, Hyung J. Chun*, Wilson Wong*, David M. Spencer‡, and Michael J. Lenardo*§ *Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 11N311, 10 Center Drive, MSC 1892, Bethesda, MD 20892; and ‡Department of Immunology, Baylor College of Medicine, Houston, TX 77030 Edited by William E. Paul, National Institutes of Health, Bethesda, MD, and approved September 12, 2001 (received for review July 12, 2001) A role for caspase-10, previously implicated in the autoimmune lymphoproliferative syndrome, in death receptor signaling has not been directly shown. Here we show that caspase-10 can function independently of caspase-8 in initiating Fas- and tumor necrosis factor-related apoptosis-inducing ligand-receptor-mediated apo- ptosis. Moreover, Fas crosslinking in primary human T cells leads to the recruitment and activation of caspase-10. Fluorescent reso- nance energy transfer analysis indicates that the death-effector domains of caspase-8 and -10 both interact with the death-effector domain of FADD. Nonetheless, we find that caspase-8 and -10 may have different apoptosis substrates and therefore potentially dis- tinct roles in death receptor signaling or other cellular processes. eath receptors (DRs) of the tumor necrosis factor receptor Dsuperfamily contain a conserved ‘‘death domain’’ in their intracellular region (1). Fas associates with an adaptor molecule, FADD, through homotypic death domain interactions (2, 3). FADD then recruits caspase-8 through homotypic interactions of death-effector domains (DEDs), leading to caspase-8 activa- tion and apoptosis (4, 5). Other DRs may also signal by recruiting caspase-8 through FADD.
    [Show full text]